These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 17050792)

  • 1. Population-based assessments of clinical drug-drug interactions: qualitative indices or quantitative measures?
    Zhou H
    J Clin Pharmacol; 2006 Nov; 46(11):1268-89. PubMed ID: 17050792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug interactions in dermatological practice.
    Tey HL; Tian EL; Tan AW
    Clin Exp Dermatol; 2008 Aug; 33(5):541-50. PubMed ID: 18801094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polypharmacy in older oncology patients and the need for an interdisciplinary approach to side-effect management.
    Sokol KC; Knudsen JF; Li MM
    J Clin Pharm Ther; 2007 Apr; 32(2):169-75. PubMed ID: 17381667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinically relevant drug interactions in the elderly].
    Jansen PA
    Ned Tijdschr Geneeskd; 2003 Mar; 147(13):595-9. PubMed ID: 12701392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for potential drug interactions in general practice.
    Bjerrum L; Gonzalez Lopez-Valcarcel B; Petersen G
    Eur J Gen Pract; 2008; 14(1):23-9. PubMed ID: 18464169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methods for assessing drug-related anticholinergic activity.
    Rudd KM; Raehl CL; Bond CA; Abbruscato TJ; Stenhouse AC
    Pharmacotherapy; 2005 Nov; 25(11):1592-601. PubMed ID: 16232021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Procedures and methods of benefit assessments for medicines in Germany].
    Bekkering GE; Kleijnen J
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and patient awareness of selected potential drug interactions with self-medication.
    Indermitte J; Reber D; Beutler M; Bruppacher R; Hersberger KE
    J Clin Pharm Ther; 2007 Apr; 32(2):149-59. PubMed ID: 17381665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinically important potential drug-drug interactions in outpatient settings.
    Aparasu R; Baer R; Aparasu A
    Res Social Adm Pharm; 2007 Dec; 3(4):426-37. PubMed ID: 18082877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [How to identify and prevent pharmacokinetically relevant drug-drug interactions].
    Ritter CA
    Med Monatsschr Pharm; 2009 Oct; 32(10):364-74; quiz 375-6. PubMed ID: 19886226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence-based drug--herbal interactions.
    Chavez ML; Jordan MA; Chavez PI
    Life Sci; 2006 Mar; 78(18):2146-57. PubMed ID: 16427091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The regulatory view on drug-drug interactions.
    Müller HJ; Gundert-Remy U
    Int J Clin Pharmacol Ther; 1994 Jun; 32(6):269-73. PubMed ID: 7921523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardionomics: a new integrative approach for screening cardiotoxicity of drug candidates.
    Gwathmey JK; Tsaioun K; Hajjar RJ
    Expert Opin Drug Metab Toxicol; 2009 Jun; 5(6):647-60. PubMed ID: 19442031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of educational level on polypharmacy and inappropriate drug use: a register-based study of more than 600,000 older people.
    Haider SI; Johnell K; Weitoft GR; Thorslund M; Fastbom J
    J Am Geriatr Soc; 2009 Jan; 57(1):62-9. PubMed ID: 19054196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A risk-based bioanalytical strategy for the assessment of antibody immune responses against biological drugs.
    Shankar G; Pendley C; Stein KE
    Nat Biotechnol; 2007 May; 25(5):555-61. PubMed ID: 17483842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychotherapeutic agents in older adults. Metabolism, bioavailability, and drug interactions.
    Steffens DC; Rama Krishnan KR
    Clin Geriatr Med; 1998 Feb; 14(1):17-31. PubMed ID: 9456333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.